128 results
424B4
ABVC
ABVC BioPharma Inc
23 May 24
Prospectus supplement with pricing info
4:30pm
price, the Company relies on assumptions which may include forecasted revenues, development timelines, reimbursement rates for R&D personnel costs … to research and development expenses when incurred.
For CDMO business unit, the Company accounts for R&D costs in accordance with Accounting Standards
424B4
ABVC
ABVC BioPharma Inc
22 May 24
Prospectus supplement with pricing info
5:00pm
and development (“R&D”) initiatives and/or working capital, as well as to repay outstanding loans if cash flow from operations is insufficient to do so. We … ongoing development activities, it is likely that it will be unable to carry out its business plans, including R&D development and expansion
424B4
ABVC
ABVC BioPharma Inc
22 May 24
Prospectus supplement with pricing info
2:31pm
price, the Company relies on assumptions which may include forecasted revenues, development timelines, reimbursement rates for R&D personnel costs … to research and development expenses when incurred.
For CDMO business unit, the Company accounts for R&D costs in accordance with Accounting Standards
POS AM
b0kcun
25 Apr 24
Prospectus update (post-effective amendment)
2:38pm
424B4
gtgosd27
5 Apr 24
Prospectus supplement with pricing info
2:47pm
8-K
EX-99.1
tfb8aztkmn7j64gu55
26 Mar 24
Entry into a Material Definitive Agreement
8:35am
DEFA14A
nducxh24zq
25 Mar 24
Additional proxy soliciting materials
4:30pm
8-K
EX-99.1
e01argdpvfu1i63l9 hz
14 Mar 24
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
9:04am
8-K
EX-99.1
ocgsb p879j1neabg
8 Feb 24
ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share
9:30am
424B4
8jo5yngu49by5ukh
17 Nov 23
Prospectus supplement with pricing info
5:00pm
424B4
r1qntnlr84kqi
17 Nov 23
Prospectus supplement with pricing info
5:00pm